13F
中

PLX PROTALIX BIOTHERAPEUTICS INC

2026Q1 · CUSIP 74365A309 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
98
Δ holders QoQ
+15
Breadth percentile
Top 21%
Whale holders
54
Δ whales
+6
Inst. holding value
$36M
New positions
27
Closed positions
12
Price momentum (1Q)
—
Put / Call
3/3

Breadth history (34 quarters)

2020Q1: Δ+3 · h=20 2020Q2: Δ+9 · h=29 2020Q3: Δ-3 · h=26 2020Q4: Δ-2 · h=24 2021Q1: Δ+14 · h=38 2021Q2: Δ-5 · h=33 2021Q3: Δ+3 · h=36 2021Q4: Δ-3 · h=33 2022Q1: Δ+0 · h=33 2022Q2: Δ-2 · h=31 2022Q3: Δ-3 · h=28 2022Q4: Δ-1 · h=27 2023Q1: Δ+8 · h=35 2023Q2: Δ+32 · h=67 2023Q3: Δ-5 · h=62 2023Q4: Δ+5 · h=67 2024Q1: Δ-2 · h=65 2024Q2: Δ+2 · h=67 2024Q3: Δ-21 · h=46 2024Q4: Δ+1 · h=47 2025Q1: Δ+17 · h=64 2025Q2: Δ+0 · h=64 2025Q3: Δ+13 · h=77 2025Q4: Δ+6 · h=83 2026Q1: Δ+15 · h=98 2020Q1: holders=20 2020Q2: holders=29 2020Q3: holders=26 2020Q4: holders=24 2021Q1: holders=38 2021Q2: holders=33 2021Q3: holders=36 2021Q4: holders=33 2022Q1: holders=33 2022Q2: holders=31 2022Q3: holders=28 2022Q4: holders=27 2023Q1: holders=35 2023Q2: holders=67 2023Q3: holders=62 2023Q4: holders=67 2024Q1: holders=65 2024Q2: holders=67 2024Q3: holders=46 2024Q4: holders=47 2025Q1: holders=64 2025Q2: holders=64 2025Q3: holders=77 2025Q4: holders=83 2026Q1: holders=98 -32 -16 +0 +16 +32 1861103 20Q120Q421Q322Q223Q123Q424Q325Q226Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 14% — —
2023Q2 Top 6% — —
2023Q1 Top 19% — —

Options Sentiment

Put holders
3
QoQ: +2
Call holders
3
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
12.6
EPS (TTM)
$0.19
EPS YoY
+280.0%
Revenue (TTM)
$0.1B
Revenue YoY
+27.8%
Quarterly Revenue & EPS (4Y)
2022-06-30: $9M 2022-09-30: $14M 2022-12-31: $9M 2023-03-31: $10M 2023-06-30: $35M 2023-09-30: $10M 2023-12-31: $10M 2024-03-31: $4M 2024-06-30: $13M 2024-09-30: $18M 2024-12-31: $18M 2025-03-31: $10M 2025-06-30: $16M 2025-09-30: $18M 2025-12-31: $9M 2026-03-31: $34M 2022-06-30: EPS -0.11 2022-09-30: EPS -0.07 2022-12-31: EPS -0.08 2023-03-31: EPS -0.05 2023-06-30: EPS 0.21 2023-09-30: EPS -0.04 2023-12-31: EPS -0.03 2024-03-31: EPS -0.06 2024-06-30: EPS -0.03 2024-09-30: EPS 0.03 2024-12-31: EPS 0.10 2025-03-31: EPS -0.05 2025-06-30: EPS 0.00 2025-09-30: EPS 0.03 2025-12-31: EPS -0.06 2026-03-31: EPS 0.22 0M 18M 35M $M -0.12 0.06 0.24 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 23 2023-06-30: PE 1972023-09-30: PE 34.72023-12-31: PE 16.32024-03-31: PE 14.22024-12-31: PE 67.32025-03-31: PE 33.42025-06-30: PE 18.52025-09-30: PE 23.32026-03-31: PE 10.4 9 108 207 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)